Cargando…
Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity
Ectopic protein overexpression in immortalised cell lines is a commonly used method to screen host factors for their antiviral activity against different viruses. However, the question remains as to what extent such artificial protein overexpression recapitulates endogenous protein function. Previou...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145288/ https://www.ncbi.nlm.nih.gov/pubmed/37111405 http://dx.doi.org/10.3390/pathogens12040519 |
_version_ | 1785034297513607168 |
---|---|
author | Meischel, Tina Fritzlar, Svenja Villalón-Letelier, Fernando Smith, Jeffrey M. Brooks, Andrew G. Reading, Patrick C. Londrigan, Sarah L. |
author_facet | Meischel, Tina Fritzlar, Svenja Villalón-Letelier, Fernando Smith, Jeffrey M. Brooks, Andrew G. Reading, Patrick C. Londrigan, Sarah L. |
author_sort | Meischel, Tina |
collection | PubMed |
description | Ectopic protein overexpression in immortalised cell lines is a commonly used method to screen host factors for their antiviral activity against different viruses. However, the question remains as to what extent such artificial protein overexpression recapitulates endogenous protein function. Previously, we used a doxycycline-inducible overexpression system, in conjunction with approaches to modulate the expression of endogenous protein, to demonstrate the antiviral activity of IFITM1, IFITM2, and IFITM3 against influenza A virus (IAV) but not parainfluenza virus-3 (PIV-3) in A549 cells. We now show that constitutive overexpression of the same IFITM constructs in A549 cells led to a significant restriction of PIV-3 infection by all three IFITM proteins. Variable IFITM mRNA and protein expression levels were detected in A549 cells with constitutive versus inducible overexpression of each IFITM. Our findings show that overexpression approaches can lead to levels of IFITM1, IFITM2, and IFITM3 that significantly exceed those achieved through interferon stimulation of endogenous protein. We propose that exceedingly high levels of overexpressed IFITMs may not accurately reflect the true function of endogenous protein, thus contributing to discrepancies when attributing the antiviral activity of individual IFITM proteins against different viruses. Our findings clearly highlight the caveats associated with overexpression approaches used to screen cellular host proteins for antiviral activity. |
format | Online Article Text |
id | pubmed-10145288 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101452882023-04-29 Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity Meischel, Tina Fritzlar, Svenja Villalón-Letelier, Fernando Smith, Jeffrey M. Brooks, Andrew G. Reading, Patrick C. Londrigan, Sarah L. Pathogens Article Ectopic protein overexpression in immortalised cell lines is a commonly used method to screen host factors for their antiviral activity against different viruses. However, the question remains as to what extent such artificial protein overexpression recapitulates endogenous protein function. Previously, we used a doxycycline-inducible overexpression system, in conjunction with approaches to modulate the expression of endogenous protein, to demonstrate the antiviral activity of IFITM1, IFITM2, and IFITM3 against influenza A virus (IAV) but not parainfluenza virus-3 (PIV-3) in A549 cells. We now show that constitutive overexpression of the same IFITM constructs in A549 cells led to a significant restriction of PIV-3 infection by all three IFITM proteins. Variable IFITM mRNA and protein expression levels were detected in A549 cells with constitutive versus inducible overexpression of each IFITM. Our findings show that overexpression approaches can lead to levels of IFITM1, IFITM2, and IFITM3 that significantly exceed those achieved through interferon stimulation of endogenous protein. We propose that exceedingly high levels of overexpressed IFITMs may not accurately reflect the true function of endogenous protein, thus contributing to discrepancies when attributing the antiviral activity of individual IFITM proteins against different viruses. Our findings clearly highlight the caveats associated with overexpression approaches used to screen cellular host proteins for antiviral activity. MDPI 2023-03-27 /pmc/articles/PMC10145288/ /pubmed/37111405 http://dx.doi.org/10.3390/pathogens12040519 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Meischel, Tina Fritzlar, Svenja Villalón-Letelier, Fernando Smith, Jeffrey M. Brooks, Andrew G. Reading, Patrick C. Londrigan, Sarah L. Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity |
title | Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity |
title_full | Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity |
title_fullStr | Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity |
title_full_unstemmed | Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity |
title_short | Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity |
title_sort | caveats of using overexpression approaches to screen cellular host ifitm proteins for antiviral activity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145288/ https://www.ncbi.nlm.nih.gov/pubmed/37111405 http://dx.doi.org/10.3390/pathogens12040519 |
work_keys_str_mv | AT meischeltina caveatsofusingoverexpressionapproachestoscreencellularhostifitmproteinsforantiviralactivity AT fritzlarsvenja caveatsofusingoverexpressionapproachestoscreencellularhostifitmproteinsforantiviralactivity AT villalonletelierfernando caveatsofusingoverexpressionapproachestoscreencellularhostifitmproteinsforantiviralactivity AT smithjeffreym caveatsofusingoverexpressionapproachestoscreencellularhostifitmproteinsforantiviralactivity AT brooksandrewg caveatsofusingoverexpressionapproachestoscreencellularhostifitmproteinsforantiviralactivity AT readingpatrickc caveatsofusingoverexpressionapproachestoscreencellularhostifitmproteinsforantiviralactivity AT londrigansarahl caveatsofusingoverexpressionapproachestoscreencellularhostifitmproteinsforantiviralactivity |